Outset Medical Inc. (OM): Price and Financial Metrics
GET POWR RATINGS... FREE!
OM Stock Price Chart Interactive Chart >
OM Price/Volume Stats
| Current price | $49.12 | 52-week high | $66.96 |
| Prev. close | $48.28 | 52-week low | $41.07 |
| Day low | $47.84 | Volume | 274,500 |
| Day high | $49.50 | Avg. volume | 417,514 |
| 50-day MA | $51.20 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 2.26B |
Outset Medical Inc. (OM) Company Bio
Outset Medical, Inc. is a medical technology company, which provides dialysis solutions to patients and healthcare providers. Its product Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
Latest OM News From Around the Web
Below are the latest news stories about Outset Medical Inc that investors may wish to consider to help them evaluate OM as an investment opportunity.
Satellite Healthcare and Outset Medical Announce Multi-Year Agreement to Increase Home Dialysis PenetrationSatellite Healthcare, a leading national not-for-profit kidney care company and Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind dialysis technology, announced a joint effort to drive home hemodialysis adoption within Satellite Healthcare’s nationwide network of dialysis centers. As part of the multi-year sales agreement, Satellite Healthcare will purchase and utilize Tablo systems for home hemodialysis. Further, the two organizations will collaborat |
Outset Medical to Present at Goldman Sachs 42nd Annual Global Healthcare ConferenceOutset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Wednesday, June 9, 2021 at 7:30am PT / 10:30am ET. |
Outset Medical Appoints MedTech Executive Katie Szyman to Board of DirectorsOutset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind device to reduce the cost and complexity of dialysis, today announced the appointment of Katie Szyman to its board of directors. Szyman, currently Corporate Vice President and General Manager of Critical Care at Edwards Lifesciences, brings more than 30 years of global medtech leadership experience. With a focus on driving sustainable, high-growth revenue, Szyman has introduced to market patient-focused innovations that also drive cost efficiencies for providers. |
What Type Of Shareholders Own The Most Number of Outset Medical, Inc. (NASDAQ:OM) Shares?Every investor in Outset Medical, Inc. ( NASDAQ:OM ) should be aware of the most powerful shareholder groups. Generally... |
Outset Medical Reports First Quarter 2021 Financial ResultsOutset Medical, Inc. (Nasdaq: OM) ("Outset" or the "Company"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the first quarter ended March 31, 2021. |
OM Price Returns
| 1-mo | 16.59% |
| 3-mo | -1.78% |
| 6-mo | -5.52% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -13.58% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...